Professor Limakatso Lebina, Director of Clinical Trials at the Africa Health Research Institute, says its important for South Africa to prepare early for rolling out new TB vaccines, which are currently undergoing clinical trials.
The institute, in northern KwaZulu-Natal, is one of the sites for the M72 Vaccine Trials which are also being conducted in six other countries.
Professor Lebina says the trial results are expected in three or four years from now.